Biotech Values

[gym gravity]

this is the previous quarters. It's leveled off at 7 analysts but grown steadily since. Next quarter I say there are 9.

Analysts


Richard Smith - JPMorgan

David Moskowitz - Caris & Company

Mark Schoenebaum - Bear Stearns

May-Kin Ho - Goldman Sachs

Jim Redick - FBR capital market

Howard Liang - Leerink Swann

and the quarter before that:

Analysts

Richard Smith - JPMorgan

Mark Schoenebaum - Bear Stearns

Howard Liang - Leerink Swann

David Spout - Goldman Sachs

Jason Kolbert - SIG

(all cut from seeking alpha)